Sun Pharma Advanced Research Company Limited (BOM:532872)
196.80
-2.65 (-1.33%)
At close: Aug 21, 2026
BOM:532872 Market Cap
BOM:532872 has a market cap or net worth of 63.84 billion as of August 21, 2026. Its market cap has increased by 33.94% in one year.
Market Cap
63.84B
Enterprise Value
69.42B
Revenue
19.09B
Ranking
n/a
PE Ratio
4.03
Stock Price
196.80
ChartMarket Cap Chart
Since July 18, 2007, BOM:532872's market cap has increased from 17.19B to 63.84B, an increase of 271.43%. That is a compound annual growth rate of 7.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 63.84B | 46.31% |
| Dec 31, 2025 | 43.63B | -32.96% |
| Dec 31, 2024 | 65.08B | -30.07% |
| Dec 29, 2023 | 93.07B | 62.05% |
| Dec 30, 2022 | 57.43B | -24.01% |
| Dec 31, 2021 | 75.58B | 48.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CORONA Remedies | 131.04B |
| Viyash Scientific | 120.57B |
| Procter & Gamble Health | 96.85B |
| Sanofi India | 77.11B |
| Bliss GVS Pharma | 61.86B |
| FDC Limited | 56.69B |
| Morepen Laboratories | 52.60B |
| Gufic Biosciences | 43.41B |